Xylo-Mepha Plus, Nasenspray

7680658680019 CH-65868 Nasenspray
Xylo-Mepha Plus, Nasenspray
Xylo-Mepha Plus, Nasenspray
Xylo-Mepha Plus, Nasenspray
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
ml
Galenic form
Nasenspray
Galenic group
Nasenmittel

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
24/02/2022
Patient information leaflet
Français
24/02/2022
Patient information leaflet
Italien
24/02/2022
Summary of Product Characteristics
Allemand
08/01/2021
Summary of Product Characteristics
Français
08/01/2021
Summary of Product Characteristics
Italien
08/01/2021

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MGML Substance Wirkstoff (Principe actif)
(N/A)
0.1 MG Substance Wirkstoff (Principe actif)
(N/A)
50.0 MGML Substance Wirkstoff (Principe actif)
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
65868
Drug name
Xylo-Mepha Plus, Nasenspray
Galenic form
NASS
ATC Code
R01AB06
Authorization status
Z
Dispensing category
D
First authorization
26/08/2016
Authorization expiration date
31/12/9999
IT Number
12.02.2.
Domain
Human medicine
Field of application
Schnupfen

Package details

Description (FR)
XYLO Mepha Plus spray nasal 10 ml
Description (DE)
XYLO Mepha Plus Nasenspray 10 ml
Market launch
26/08/2016
Narcotic (BTM)
No